06/17/22 1:25 AMOTC : RLFTY, RLFTF low floatRelief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange CommissionRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), announced today that it has filed Amendment No. 3 to its Registration Statement on Form 20‑F (" Registration Statement") with the U.S. Securities and ExchangeRHEA-AIneutral
06/13/22 1:25 AMOTC : RLFTY, RLFTF low floatRelief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for AviptadilRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRxRHEA-AIneutral
06/08/22 1:25 AMOTC : RLFTF, RLFTY Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet needs, reported today that its collaboration partner,RHEA-AIneutral
06/01/22 1:30 AMOTC : RLFTF, RLFTY Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SARELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (" Relief" or the " Company"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that, at its AnnualRHEA-AIneutral
05/31/22 1:30 AMOTC : RLFTF, RLFTY covid-19Relief Provides a Corporate Update and Comments on the Recently Announced DSMB Update on the U.S. National Institutes of Health (NIH) Study of Intravenous Aviptadil in Critical COVID-19 PatientsRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet needs, today provided a corporate update. 1) WhileRHEA-AIneutral
05/26/22 7:20 AMOTC : RLFTF, RLFTY covid-19Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19RELIEF THERAPEUTICS Holding SA (SIX:RLF), (OTCQB:RLFTF, RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRxRHEA-AIneutral
05/23/22 1:20 AMOTC : RLFTY, RLFTF low floatRelief Therapeutics Expands U.S. Commercial TeamRELIEF THERAPEUTICS Holding SARHEA-AIneutral
05/11/22 1:10 AMOTC : RLFTY, RLFTF low floatRelief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange CommissionRELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (" Relief"), announced today that it has filed Amendment No. 2 to its Registration Statement on Form 20-F (" Registration Statement") with the U.S. Securities and Exchange Commission ("RHEA-AIneutral
05/09/22 2:05 AMOTC : RLFTF, RLFTY conferencesRelief Therapeutics to Participate in Industry and Investor Conferences in MayRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the followingRHEA-AIneutral
05/06/22 1:40 AMOTC, Nasdaq : RLFTF, RLFTY, ACER Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International ConferenceAcer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) ("Relief"), today announced the presentation of data evaluating the bioavailability,RHEA-AIneutral
